Invention Grant
- Patent Title: Polypeptides and antibodies for treating HBV infection and related diseases
-
Application No.: US14406940Application Date: 2013-06-06
-
Publication No.: US09751914B2Publication Date: 2017-09-05
- Inventor: Quan Yuan , Tianying Zhang , Wenxin Luo , Yixin Chen , Jun Zhang , Ningshao Xia
- Applicant: XIAMEN UNIVERSITY , XIAMEN INNOVAX BIOTECH CO., LTD.
- Applicant Address: CN Xiamen CN Xiamen
- Assignee: Xiamen University,Xiamen Innovax Biotech Co., Ltd.
- Current Assignee: Xiamen University,Xiamen Innovax Biotech Co., Ltd.
- Current Assignee Address: CN Xiamen CN Xiamen
- Agency: Honigman Miller Schwartz and Cohn LLP
- Agent Thomas A. Wootton, Esq.; Jonathan P. O'Brien
- Priority: CN201210190329 20120611
- International Application: PCT/CN2013/076832 WO 20130606
- International Announcement: WO2013/185558 WO 20131219
- Main IPC: C07K14/005
- IPC: C07K14/005 ; G01N33/569 ; C07K16/08 ; A61K39/12 ; C07K7/06 ; C12P21/02 ; A61K39/00 ; C12N7/00
Abstract:
The present invention relates to epitope peptides (or mutants thereof) for treating hepatitis B virus infection, recombinant proteins comprising such epitope peptides (or mutants thereof) and carrier proteins, and uses of such epitope peptides (or mutants thereof) and recombinant proteins. The present invention also relates to antibodies against such epitope peptides, cell lines producing said antibodies, and uses thereof. Furthermore, the present invention relates to vaccines or pharmaceutical compositions for treating or alleviating one or more symptoms associated with hepatitis B virus infection, which comprise the recombinant proteins or antibodies according to the invention, respectively.
Public/Granted literature
- US20150246948A1 POLYPEPTIDES AND ANTIBODIES FOR TREATING HBV INFECTION AND RELATED DISEASES Public/Granted day:2015-09-03
Information query
